Pierre Deharo

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

Thomas Cuisset, Pierre Deharo, Jacques Quilici et al. · European Heart Journal · 2017 · 403 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

Giuseppe De Luca, Monica Verdoia, Miha Čerček et al. · Journal of the American College of Cardiology · 2020 · 209 citations · Full text

Medicine, Internal Medicine, Surgery +7

Beta-Blocker Interruption or Continuation after Myocardial Infarction

Johanne Silvain, Guillaume Cayla, Émile Ferrari et al. · New England Journal of Medicine · 2024 · 144 citations

Pharmacy, Cardiology, Pharmacotherapy +14

Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement

Pierre Deharo, Arnaud Bisson, Julien Herbert et al. · Journal of the American College of Cardiology · 2020 · 143 citations · Full text

Medicine, Cardiology, Surgery +12

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 130 citations

Medicine, Cardiology, Pharmacology +14